Merkel Cell Polyomavirus Encodes Circular RNAs (circRNAs) Enabling a Dynamic circRNA/microRNA/mRNA Regulatory Network

Covalently closed circular RNAs were recently described in the human DNA tumor viruses Epstein-Barr virus (EBV), Kaposi’s sarcoma-associated herpesvirus (KSHV), and human papillomavirus (HPV). Here, we show that MCV, another DNA tumor virus, generates circRNAs from its early regulatory region in concert with T antigen linear transcripts. ABSTRACT Viral noncoding RNAs have acquired increasing prominence as important regulators of infection and mediators of pathogenesis. Circular RNAs (circRNAs) generated by backsplicing events have been identified in several oncogenic human DNA viruses. Here, we show that Merkel cell polyomavirus (MCV), the etiologic cause of ∼80% of Merkel cell carcinomas (MCCs), also expresses circular RNAs. By RNase R-resistant RNA sequencing, four putative circRNA backsplice junctions (BSJs) were identified from the MCV early region (ER). The most abundantly expressed MCV circRNA, designated circMCV-T, is generated through backsplicing of all of ER exon II to form a 762-nucleotide (nt) circular RNA molecule. Curiously, circMCV-T, as well as two other less abundantly expressed putative MCV circRNAs, overlaps in a complementary fashion with the MCV microRNA (miRNA) locus that encodes MCV-miR-M1. circMCV-T is consistently detected in concert with linear T antigen transcripts throughout infection, suggesting a crucial role for this RNA molecule in the regulatory functions of the early region, known to be vital for viral replication. Knocking out the hairpin structure of MCV-miR-M1 in genomic early region expression constructs and using a new high-efficiency, recombinase-mediated, recircularized MCV molecular clone demonstrates that circMCV-T levels decrease in the presence of MCV-miR-M1, underscoring the interplay between MCV circRNA and miRNA. Furthermore, circMCV-T partially reverses the known inhibitory effect of MCV-miR-M1 on early gene expression. RNase R-resistant RNA sequencing of lytic rat polyomavirus 2 (RatPyV2) identified an analogously located circRNA, stipulating a crucial, conserved regulatory function of this class of RNA molecules in the family of polyomaviruses. IMPORTANCE Covalently closed circular RNAs were recently described in the human DNA tumor viruses Epstein-Barr virus (EBV), Kaposi’s sarcoma-associated herpesvirus (KSHV), and human papillomavirus (HPV). Here, we show that MCV, another DNA tumor virus, generates circRNAs from its early regulatory region in concert with T antigen linear transcripts. MCV circMCV-T interacts with another MCV noncoding RNA, miR-M1, to functionally modulate early region transcript expression important for viral replication and long-term episomal persistence. This work describes a dynamic regulatory network integrating circRNA/miRNA/mRNA biomolecules and underscores the intricate functional modulation between several classes of polyomavirus-encoded RNAs in the control of viral replication.

[1]  Arturo Díaz Quiroz Circular , 1856, The North-Western Medical and Surgical Journal.

[2]  Jian-ning Chen,et al.  Epstein–Barr virus‐derived circular RNA LMP2A induces stemness in EBV‐associated gastric cancer , 2020, EMBO reports.

[3]  A. McBride,et al.  Human Papillomavirus Quasivirus Production and Infection of Primary Human Keratinocytes , 2020, Current protocols in microbiology.

[4]  P. Moore,et al.  Kaposi’s Sarcoma-Associated Herpesvirus-Encoded circRNAs Are Expressed in Infected Tumor Tissues and Are Incorporated into Virions , 2020, mBio.

[5]  R. Zahedi,et al.  The Ubiquitin-Specific Protease Usp7, a Novel Merkel Cell Polyomavirus Large T-Antigen Interaction Partner, Modulates Viral DNA Replication , 2019, Journal of Virology.

[6]  J. Utikal,et al.  Characterization of six Merkel cell polyomavirus‐positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration , 2019, International journal of cancer.

[7]  Xiaowei Zhan,et al.  Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus , 2019, Nature Communications.

[8]  B. Damania Faculty Opinions recommendation of Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[9]  Gebert Lfr,et al.  Regulation of microRNA function in animals , 2019 .

[10]  Walter N. Moss,et al.  Comparative Analysis of Gammaherpesvirus Circular RNA Repertoires: Conserved and Unique Viral Circular RNAs , 2018, Journal of Virology.

[11]  J. Spouge,et al.  Discovery of Kaposi’s sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA , 2018, Proceedings of the National Academy of Sciences.

[12]  Yuan Gao,et al.  Circular RNA identification based on multiple seed matching , 2018, Briefings Bioinform..

[13]  S. Swerdlow,et al.  Circular DNA tumor viruses make circular RNAs , 2018, Proceedings of the National Academy of Sciences.

[14]  F. Nicassio,et al.  Endogenous transcripts control miRNA levels and activity in mammalian cells by target-directed miRNA degradation , 2018, Nature Communications.

[15]  Walter N. Moss,et al.  The Epstein Barr virus circRNAome , 2018, PLoS pathogens.

[16]  Yuan Chang,et al.  Characterization of a Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma Cell Line CVG-1 , 2018, Front. Microbiol..

[17]  David P. Bartel,et al.  A Network of Noncoding Regulatory RNAs Acts in the Mammalian Brain , 2018, Cell.

[18]  L. Holdt,et al.  Molecular roles and function of circular RNAs in eukaryotic cells , 2017, Cellular and Molecular Life Sciences.

[19]  Carmen Birchmeier,et al.  Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function , 2017, Science.

[20]  Petar Glažar,et al.  A map of human circular RNAs in clinically relevant tissues , 2017, Journal of Molecular Medicine.

[21]  M. Ustav,et al.  Analysis of Human Papillomavirus Genome Replication Using Two‐ and Three‐Dimensional Agarose Gel Electrophoresis , 2017, Current protocols in microbiology.

[22]  Dawood B. Dudekula,et al.  High-purity circular RNA isolation method (RPAD) reveals vast collection of intronic circRNAs , 2017, Nucleic acids research.

[23]  N. Rajewsky,et al.  Translation of CircRNAs , 2017, Molecular cell.

[24]  N. Rajewsky,et al.  Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis , 2017, Molecular cell.

[25]  Yang Zhang,et al.  Extensive translation of circular RNAs driven by N6-methyladenosine , 2017, Cell Research.

[26]  Amaresh C Panda,et al.  Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1 , 2017, RNA biology.

[27]  L. Rigatti,et al.  Identification and Characterization of Novel Rat Polyomavirus 2 in a Colony of X-SCID Rats by P-PIT assay , 2016, mSphere.

[28]  G. Stephanopoulos,et al.  Merkel Cell Polyomavirus Small T Antigen Promotes Pro-Glycolytic Metabolic Perturbations Required for Transformation , 2016, PLoS pathogens.

[29]  J. Salzman,et al.  Detecting circular RNAs: bioinformatic and experimental challenges , 2016, Nature Reviews Genetics.

[30]  Weining Yang,et al.  Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2 , 2016, Nucleic acids research.

[31]  Igor Ulitsky,et al.  Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor , 2015, Nucleic acids research.

[32]  C. Buck,et al.  The Oncogenic Small Tumor Antigen of Merkel Cell Polyomavirus Is an Iron-Sulfur Cluster Protein That Enhances Viral DNA Replication , 2015, Journal of Virology.

[33]  Nikolaus Rajewsky,et al.  Identification and Characterization of Circular RNAs As a New Class of Putative Biomarkers in Human Blood , 2015, PloS one.

[34]  S. Cherry,et al.  Combinatorial control of Drosophila circular RNA expression by intronic repeats, hnRNPs, and SR proteins , 2015, Genes & development.

[35]  T. Günther,et al.  A Comprehensive Analysis of Replicating Merkel Cell Polyomavirus Genomes Delineates the Viral Transcription Program and Suggests a Role for mcv-miR-M1 in Episomal Persistence , 2015, PLoS pathogens.

[36]  L. Laurent,et al.  Statistically based splicing detection reveals neural enrichment and tissue-specific induction of circular RNA during human fetal development , 2015, Genome Biology.

[37]  K. Woolard,et al.  Identification of a polyomavirus microRNA highly expressed in tumors. , 2015, Virology.

[38]  Griffiths Da,et al.  Merkel Cell Polyomavirus Small T Antigen Mediates Microtubule Destabilization To Promote Cell Motility and Migration , 2014, Journal of Virology.

[39]  N. Rajewsky,et al.  circRNA biogenesis competes with pre-mRNA splicing. , 2014, Molecular cell.

[40]  T. Dobner,et al.  High-Affinity Rb Binding, p53 Inhibition, Subcellular Localization, and Transformation by Wild-Type or Tumor-Derived Shortened Merkel Cell Polyomavirus Large T Antigens , 2013, Journal of Virology.

[41]  J. Kjems,et al.  Circular RNA and miR-7 in cancer. , 2013, Cancer research.

[42]  Julia Salzman,et al.  Cell-Type Specific Features of Circular RNA Expression , 2013, PLoS genetics.

[43]  C. Camacho,et al.  Merkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by targeting the cellular ubiquitin ligase SCFFbw7. , 2013, Cell host & microbe.

[44]  M. Daugherty,et al.  Identification of an overprinting gene in Merkel cell polyomavirus provides evolutionary insight into the birth of viral genes , 2013, Proceedings of the National Academy of Sciences.

[45]  Fabio Pastorino,et al.  Abstract 5609: Bortezomib enhanced cytotoxic effects of novel sTRAIL-targeted nanocarriers against neuroectodermal tumors . , 2013 .

[46]  Sebastian D. Mackowiak,et al.  Circular RNAs are a large class of animal RNAs with regulatory potency , 2013, Nature.

[47]  O. Rozenblatt-Rosen,et al.  Merkel Cell Polyomavirus Large T Antigen Has Growth-Promoting and Inhibitory Activities , 2013, Journal of Virology.

[48]  Michael K. Slevin,et al.  Circular RNAs are abundant, conserved, and associated with ALU repeats. , 2013, RNA.

[49]  J. Kirkwood,et al.  Characterization of an early passage Merkel cell polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice. , 2013, Journal of virological methods.

[50]  Jingwei Cheng,et al.  Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. , 2012, The Journal of clinical investigation.

[51]  Xin Wang,et al.  Bromodomain Protein Brd4 Plays a Key Role in Merkel Cell Polyomavirus DNA Replication , 2012, PLoS pathogens.

[52]  Johannes P. W. Grimm,et al.  An intact retinoblastoma protein‐binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells , 2012, International journal of cancer.

[53]  Charles Gawad,et al.  Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types , 2012, PloS one.

[54]  Jørgen Kjems,et al.  miRNA‐dependent gene silencing involving Ago2‐mediated cleavage of a circular antisense RNA , 2011, The EMBO journal.

[55]  Yuan Chang,et al.  Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. , 2011, The Journal of clinical investigation.

[56]  Xi Liu,et al.  Cellular and Viral Factors Regulating Merkel Cell Polyomavirus Replication , 2011, PloS one.

[57]  S. Barik,et al.  MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions. , 2011, Molecular and cellular pharmacology.

[58]  M. Kay,et al.  A Simple And Rapid Minicircle DNA Vector Manufacturing System , 2010, Nature Biotechnology.

[59]  Zhiping Weng,et al.  Target RNA–Directed Trimming and Tailing of Small Silencing RNAs , 2010, Science.

[60]  J. Steitz,et al.  Down-Regulation of a Host MicroRNA by a Herpesvirus saimiri Noncoding RNA , 2010, Science.

[61]  Yuan Chang,et al.  Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens , 2010, Journal of Virology.

[62]  A. Bohm,et al.  The Minimum Replication Origin of Merkel Cell Polyomavirus Has a Unique Large T-Antigen Loading Architecture and Requires Small T-Antigen Expression for Optimal Replication , 2009, Journal of Virology.

[63]  J. Becker,et al.  Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays , 2009, International journal of cancer.

[64]  G. Seo,et al.  Merkel cell polyomavirus encodes a microRNA with the ability to autoregulate viral gene expression. , 2009, Virology.

[65]  Yuan Chang,et al.  T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus , 2008, Proceedings of the National Academy of Sciences.

[66]  P. Moore,et al.  Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma , 2008, Science.

[67]  Frank Speleman,et al.  Combined karyotyping, CGH and M‐FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma , 2002, International journal of cancer.

[68]  C. Cocquerelle,et al.  Mis‐splicing yields circular RNA molecules , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[69]  G. Carmichael,et al.  Polyomavirus late pre-mRNA processing: DNA replication-associated changes in leader exon multiplicity suggest a role for leader-to-leader splicing in the early-late switch , 1990, Journal of virology.

[70]  G. Carmichael,et al.  Leader-to-leader splicing is required for efficient production and accumulation of polyomavirus late mRNAs , 1989, Journal of virology.

[71]  G. Carmichael,et al.  Polyomavirus early-late switch is not regulated at the level of transcription initiation and is associated with changes in RNA processing. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[72]  M. L. Le Beau,et al.  Establishment and characterization of a neuroendocrine skin carcinoma cell line. , 1987, Laboratory investigation; a journal of technical methods and pathology.